HistoSonics
Ann Arbor, GB · 9 known investors
Histosonics develops histotripsy technology, a non-invasive ultrasound-based treatment modality for physicians to use in clinical procedures. The company aims to bring this novel therapeutic approach to patients worldwide.
Founders & leadership
WC
Wen ChenDirector
TT
Tom TefftDirector
MB
Michael BlueExecutive Officer, Director
GB
Gerry BrunkDirector
JA
Jim AdoxDirector
KK
Kadir KadhiresanDirector
FL
Fred LeeDirector
Investors · 9
Alpha Wave GlobalMiami
Amzak HealthNew York
Early Stage Partners, LPCleveland
HealthQuest CapitalRedwood City
Lumira VenturesToronto · $1M – $10Mvia Gerry Brunk · board
Michigan Capital NetworkGrand Rapids
Bezos Expeditionsreported
Fletcher Spaght, Inc.reportedBostonvia Renard Charity · board
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M
Reported raises · per SEC filings
Form D private placements▶$102MraisedAug 2024 · 39 investors · Other Health CareRule 506(b)
▶$102MraisedAug 2024 · 39 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Fred Lee, Jr.Director
- Gerry BrunkDirector
- Wen ChenDirector
- Michael BlueExecutive Officer, Director
- V. Kadir KadhiresanDirector
- Tom TefftDirector
- Chris DimitropoulosDirector
- Erica RogersDirector
- James AdoxDirector
- Offering amount
- $102M
- Amount sold
- $102M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$85MraisedDec 2022 · 38 investors · Other Health CareRule 506(b)
▶$85MraisedDec 2022 · 38 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Wen ChenDirector
- Tom TefftDirector
- Michael BlueExecutive Officer, Director
- Gerry BrunkDirector
- Jim AdoxDirector
- Kadir KadhiresanDirector
- Fred LeeDirector
- Offering amount
- $85M
- Amount sold
- $85M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40.8MraisedJun 2020 · 24 investors · Other Health CareRule 506(b)
▶$40.8MraisedJun 2020 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gerry BrunkDirector
- Michael BlueExecutive Officer, Director
- Richard Eric BoslerExecutive Officer
- James AdoxDirector
- Thomas TefftDirector
- Nikita KulkarniDirector
- Fred LeeDirector
- Wen ChenDirector
- Kadir KadhiresanDirector
- Offering amount
- $40.8M
- Amount sold
- $40.8M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$47.4MraisedApr 2019 · 44 investors · Other Health CareRule 506(b)
▶$47.4MraisedApr 2019 · 44 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael BlueExecutive Officer, Director
- James AdoxDirector
- Fred LeeDirector
- Gerry BrunkDirector
- Gregory SorensenDirector
- V. Kadir KadhiresanDirector
- Tom TefftDirector
- Offering amount
- $47.4M
- Amount sold
- $47.4M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedMar 2019 · 34 investors · Other Health CareRule 506(b)
▶$7MraisedMar 2019 · 34 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert MorffDirector
- Fred LeeDirector
- Jon FreemanExecutive Officer
- Josh KingExecutive Officer
- Dan BulverExecutive Officer
- Andrew Von EschenbachDirector
- Mike DanielExecutive Officer
- James AdoxDirector
- Josh StopekDirector
- Tom TefftDirector
- Michael BlueExecutive Officer, Director
- Akhil TripathiExecutive Officer
- Linda TuftsDirector
- Offering amount
- $7M
- Amount sold
- $7M
- Minimum investment
- $6.2K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.3MraisedFeb 2017 · 13 investors · Other Health CareRule 506(b)
▶$8.3MraisedFeb 2017 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert MorffDirector
- Andrew Von EschenbachDirector
- Fred Lee, Jr.Director
- Michael BlueExecutive Officer, Director
- M. Christine GibbonsExecutive Officer
- Renard CharityDirector
- James AdoxDirector
- Offering amount
- $13.3M
- Amount sold
- $8.3M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedAug 2015 · 10 investors · Other Health CareRule 506(b)
▶$2.1MraisedAug 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- M. Christine GibbonsExecutive Officer, Director
- Thomas DavisonExecutive Officer, Director
- James AdoxDirector
- Robert MorffDirector
- Andrew Von EschenbachDirector
- Renard CharityDirector
- Offering amount
- $3M
- Amount sold
- $2.1M
- Minimum investment
- $15K
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.